Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas.

Brucellosis is a common zoonosis in many parts of the world; the best regimen for the treatment of brucellosis has not been clearly determined. We have carried out a multicenter, open, controlled trial in five general hospitals in Spain to compare the efficacy and safety of doxycycline and rifampin...

詳細記述

保存先:

書誌詳細
出版年:	Antimicrob Agents Chemother
主要な著者:	Solera, J, Rodríguez-Zapata, M, Geijo, P, Largo, J, Paulino, J, Sáez, L, Martínez-Alfaro, E, Sánchez, L, Sepulveda, M A, Ruiz-Ribó, M D
フォーマット:	Artigo
言語:	Inglês
出版事項:	American Society for Microbiology (ASM) 1995
主題:	Research Article
オンライン･アクセス:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162881/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8540716/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.9.2061
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas.

類似資料